Molecular Pathogenesis of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Narrative Review
Open Access
- 27 May 2025
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 15 (6) , 772
Abstract
Pulmonary arterial hypertension (PAH) is a lethal condition marked by the proliferation and remodeling of small pulmonary arteries, ultimately leading to right ventricular hypertrophy and right heart failure. PAH secondary to connective tissue diseases (CTDs) is a progressive complication with a complex pathogenesis that results in the reduced efficacy of vasodilation-based therapies and poor clinical outcomes. Systemic sclerosis is the most commonly associated CTD with PAH in Western countries and has been most extensively investigated. Systemic lupus erythematosus and other CTDs may also be associated with PAH; however, they are less studied. In this review, we explore the general pathobiology of PAH, with a particular emphasis on recent advances in the molecular pathogenesis of CTD-PAH, including endothelial cell dysfunction, dysregulated cell proliferation and vascular remodeling, extracellular matrix remodeling, in situ thrombosis, right ventricular dysfunction, genetic aberrations, and immune dysregulation. We also conduct a thorough investigation into the potential serum biomarkers and immune dysregulation associated with CTD-PAH, summarizing the associated autoantibodies, cytokines, and chemokines. Furthermore, relevant animal models that may help unravel the pathogenesis and contribute to the development of new treatments are also reviewed.Keywords
Funding Information
- National Science and Technology Council, Taiwan (NSTC 113-2314-B-281-007-, 111-2314-B-281-006-MY3)
This publication has 225 references indexed in Scilit:
- Association of Anemic Hypoxia and Increased Pulmonary Artery Systolic Pressure in Patients With Systemic Lupus ErythematosusArthritis Care & Research, 2015
- Epicutaneous Application of Toll‐like Receptor 7 Agonists Leads to Systemic Autoimmunity in Wild‐Type Mice: A New Model of Systemic Lupus ErythematosusArthritis & Rheumatology, 2013
- A rare polymorphism in the gene for Toll‐like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediatorsArthritis & Rheumatism, 2011
- Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertensionArthritis & Rheumatism, 2011
- Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosisArthritis & Rheumatism, 2011
- Targeting ADAM‐17/notch signaling abrogates the development of systemic sclerosis in a murine modelArthritis & Rheumatism, 2010
- Association of a KCNA5 gene polymorphism with systemic sclerosis–associated pulmonary arterial hypertension in the European Caucasian populationArthritis & Rheumatism, 2010
- Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblastsArthritis & Rheumatism, 2006
- Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosisArthritis & Rheumatism, 2002
- Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus seraArthritis & Rheumatism, 1999